Oxford Gene Technology Ltd:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Oxford Gene Technology Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C12091
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Oxford Gene Technology Ltd (OGT) is a provider of genetics research solutions. The company’s products comprise fish probes, custom cancer panels, custom AML panel, custom breast cancer panel, custom FH panel, core MPN panel, ovarian cancer panel, myeloid panel and others. It provides medical research exome array, austim research array and epilepsy research array. OGT offers services such as targeted sequencing services, sureseq solid tumour panel sequencing service, RNA-seq service, miRNA analysis, gene expression analysis, cytosure services and aCGH for CNV analysis. The company’s are used in cancer research, clinical genetics research, cytogenetics research, molecular genetics research, and pre-implantation genetic screening. OGT is headquartered in Begbroke, the UK.

Oxford Gene Technology Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Oxford Gene Technology Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Oxford Gene Technology Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Oxford Gene Technology Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Oxford Gene Technology Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Oxford Gene Technology Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Oxford Gene Technology Ltd, Medical Equipment, Deal Details 10
Partnerships 10
Institute of Cancer Research Enters Into Licensing Agreement With Oxford Gene Technology For Prostate Cancer 10
Oxford Gene Technology Enters Into Licensing Agreement With Oslo University Hospital And University of Oslo 11
Oxford Gene Enters Co-Development Agreement With Emory Genetics For New CGH Arrays 12
Oxford Gene Enters into Licensing Agreement with Wellcome Trust Sanger Institute 13
Oxford Gene Technology Enters Into Licensing Agreement With Cancer Cytogenomics Microarray Consortium 14
Asset Transactions 15
Sengenics Acquires Protein Array Technology Platform from Oxford Gene Technology 15
Acquisition 16
Sysmex Acquires Oxford Gene Technology 16
Oxford Gene Technology Acquires Cytocell, Genomic Medicine Company 17
Oxford Gene Technology Ltd – Key Competitors 18
Oxford Gene Technology Ltd – Key Employees 19
Oxford Gene Technology Ltd – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Strategy And Business Planning 21
Nov 08, 2018: OGT further expands global direct sales and support into Asia-Pacific 21
Corporate Communications 22
Apr 09, 2018: OGT announces organisational changes 22
Product News 23
Apr 25, 2017: OGT’s expanded NGS cancer panels enable sequencing of difficult genes 23
Other Significant Developments 24
Jul 02, 2018: OGT expands direct sales and support infrastructure in Europe 24
Jun 12, 2018: OGT expands custom NGS cancer panel content 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Oxford Gene Technology Ltd, Medical Equipment, Key Facts 2
Oxford Gene Technology Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Oxford Gene Technology Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Oxford Gene Technology Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Oxford Gene Technology Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Oxford Gene Technology Ltd, Deals By Market, 2012 to YTD 2018 8
Oxford Gene Technology Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Institute of Cancer Research Enters Into Licensing Agreement With Oxford Gene Technology For Prostate Cancer 10
Oxford Gene Technology Enters Into Licensing Agreement With Oslo University Hospital And University of Oslo 11
Oxford Gene Enters Co-Development Agreement With Emory Genetics For New CGH Arrays 12
Oxford Gene Enters into Licensing Agreement with Wellcome Trust Sanger Institute 13
Oxford Gene Technology Enters Into Licensing Agreement With Cancer Cytogenomics Microarray Consortium 14
Sengenics Acquires Protein Array Technology Platform from Oxford Gene Technology 15
Sysmex Acquires Oxford Gene Technology 16
Oxford Gene Technology Acquires Cytocell, Genomic Medicine Company 17
Oxford Gene Technology Ltd, Key Competitors 18
Oxford Gene Technology Ltd, Key Employees 19
Oxford Gene Technology Ltd, Subsidiaries 20

List of Figures
Oxford Gene Technology Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Oxford Gene Technology Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Oxford Gene Technology Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Oxford Gene Technology Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Oxford Gene Technology Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Oxford Gene Technology Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Oxford Gene Technology Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Oxford Gene Technology Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Oxford Gene Technology Ltd:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kellstrom Defense Aerospace, Inc.:企業の戦略・SWOT・財務情報
    Kellstrom Defense Aerospace, Inc. - Strategy, SWOT and Corporate Finance Report Summary Kellstrom Defense Aerospace, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Suburban Propane Partners LP (SPH):企業の財務・戦略的SWOT分析
    Summary Suburban Propane Partners LP (Suburban Propane) distributes and markets energy-related products. The company supplies propane, fuel oil and refined fuels, and markets natural gas and electricity in deregulated markets. It also provides installation and service of various types of whole-house …
  • Genedata AG-医療機器分野:企業M&A・提携分析
    Summary Genedata AG (Genedata) is a healthcare technology company that transforms data into software solutions. The company delivers enterprise solutions for data analytics that streamline research and development workflows and improve research productivity. Its products include genedata biologics, …
  • Heptares Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Heptares Therapeutics Ltd (Heptares) a subsidiary of Sosei Group Corp is a drug discovery company that develops small-molecule drugs. The company develops drugs for targeting G-protein-coupled receptors by utilizing its drug discovery technology platforms. Its technology platforms comprise S …
  • 21st Century Oncology Inc:企業の戦略的SWOT分析
    21st Century Oncology Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • APR Energy Ltd:電力:M&Aディール及び事業提携情報
    Summary APR Energy Ltd (APR), formerly APR Energy plc, is an energy solutions and services provider. The company installs, owns, operates and maintains power plants for applications such as bridging power, distributed power, grid stability and support, emergency power, industrial generation and peak …
  • Triangle Capital Corp:企業のM&A・事業提携・投資動向
    Triangle Capital Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Triangle Capital Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Svenska Cellulosa Aktiebolaget:企業の戦略・SWOT・財務分析
    Svenska Cellulosa Aktiebolaget - Strategy, SWOT and Corporate Finance Report Summary Svenska Cellulosa Aktiebolaget - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • LendingClub Corporation (LC):企業の財務・戦略的SWOT分析
    LendingClub Corporation (LC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Regal Entertainment Group:企業の戦略・SWOT・財務情報
    Regal Entertainment Group - Strategy, SWOT and Corporate Finance Report Summary Regal Entertainment Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Tourism Holdings Limited
    Tourism Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Tourism Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Koch Enterprises, Inc.:企業の戦略的SWOT分析
    Koch Enterprises, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • NovaBay Pharmaceuticals Inc (NBY)-医療機器分野:企業M&A・提携分析
    Summary NovaBay Pharmaceuticals Inc (NovaBay), formerly NovaCal Pharmaceuticals Inc is a biopharmaceutical company that develops eyecare products. The company’s products include daily lid and lash hygiene spray solution, skin and wound cleanser, and cosetic procedures. Its daily lid and lash hygiene …
  • EpiVax Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary EpiVax Inc (EpiVax) develops analytical capabilities in the field of computational immunology. Its product pipeline includes Tregitopes; deimmunization projects including deimmunized botox and deimmunized FVIII; and biodefense vaccines. Tregitopes are linear sequences of amino acids which ac …
  • Legian Beach Hotel
    Legian Beach Hotel - Strategy, SWOT and Corporate Finance Report Summary Legian Beach Hotel - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • KeyCorp (KEY)-エネルギー分野:企業M&A・提携分析
    Summary KeyCorp (KeyCorp) is a financial holding company that offers a range of retail and commercial banking, consumer finance, commercial mortgage and special servicing, commercial leasing, investment management, and investment banking products and services to individuals, corporate, and instituti …
  • Scientex Bhd (SCIENTX):企業の財務・戦略的SWOT分析
    Summary Scientex Bhd (Scientex) is a manufacturer and supplier of packaging products and component parts for automotive interior. The company operates through stretch and custom film, converting, specialty products and property development divisions. It offers lamination base, general, barrier and a …
  • Capitol Health Ltd (CAJ):企業の財務・戦略的SWOT分析
    Summary Capitol Health Ltd (Capitol Health) is a diagnostic imaging service provider. The company offers services such as bone densitomety, computer tomography, cone beam CT, CT angiography, doppler, echocardiography, fluoroscopy, general X-ray, magnetic resonance imaging, mammography, nuclear medic …
  • Detour Gold Corp
    Detour Gold Corp - Strategy, SWOT and Corporate Finance Report Summary Detour Gold Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • MannKind Corp (MNKD):製薬・医療:M&Aディール及び事業提携情報
    Summary MannKind Corp (MannKind) is a biopharmaceutical company that develops and commercializes inhaled therapeutic products for patients suffering from diabetes and pulmonary arterial hypertension. Its flagship product, Afrezza is a US FDA approved rapid-action inhaled insulin used to control high …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆